Origins
When was SNAP-8 created?
SNAP-8 is a cosmetic-sector peptide, and an extension of an earlier one from the same company.
The short answer
| Date | The 2000s |
| Who | Lipotec |
| Where | Barcelona, Spain |
| Origin | Designed, not found — it does not occur naturally in this form. |
Where it came from
The predecessor is acetyl hexapeptide-8, sold as Argireline, which is six residues modelled on the N-terminal end of a protein called SNAP-25. SNAP-8 extends that to eight residues, on the reasoning that a longer stretch of the parent sequence would compete more effectively.
This is a different world from most of the compounds on this page. Cosmetic peptides are developed by ingredient houses, named under the INCI system rather than by international nonproprietary name, and sold to formulators rather than through trials. The development record is correspondingly commercial.
The 2000s is the right level of precision. Lipotec’s peptide range was built out across that decade and the specific year for this member is not clearly documented in public sources.
Why it is called that
SNAP for SNAP-25, the parent protein the sequence is modelled on. 8 for the number of residues.
Where it stands now
SNAP-8 is used as a cosmetic ingredient under INCI names such as acetyl octapeptide-3. That is a different regulatory category from material supplied for laboratory work.
What this page does not say
Nothing above is a statement about what SNAP-8 does in a body, and none of it is guidance on use. A compound’s history is a record of laboratories and dates; it is not evidence for anything, and the fact that a programme was looking for something is not a finding that it was found.
More on SNAP-8
What is SNAP-8? · The full timeline · SNAP-8 — sizes and prices
